Nicolaas K. Franken
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 58 publications
Addition of PARP1-inhibition enhances chemoradiotherapy and thermoradiotherapy when treating cervical cancer in an in vivo mouse model.
Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
Published: January 21, 2025
Towards Personalized Radiotherapy in Pelvic Cancer: Patient-Related Risk Factors for Late Radiation Toxicity.
Journal: Current oncology (Toronto, Ont.)
Published: November 11, 2024
Genetic markers of late radiation toxicity in the era of image-guided radiotherapy: lower toxicity rates reduce the predictive value of γ-H2AX foci decay ratio in patients undergoing pelvic radiotherapy.
Journal: Radiation oncology (London, England)
Published: March 28, 2024
Radiosensitization by Hyperthermia Critically Depends on the Time Interval.
Journal: International journal of radiation oncology, biology, physics
Published: July 21, 2023
Elevated temperatures and longer durations improve the efficacy of oxaliplatin- and mitomycin C-based hyperthermic intraperitoneal chemotherapy in a confirmed rat model for peritoneal metastasis of colorectal cancer origin.
Journal: Frontiers in oncology
Published: December 13, 2022
Non-Invasive Imaging and Scoring of Peritoneal Metastases in Small Preclinical Animal Models Using Ultrasound: A Preliminary Trial.
Journal: Biomedicines
Published: April 05, 2022
Preclinical In Vivo-Models to Investigate HIPEC; Current Methodologies and Challenges.
Journal: Cancers
Published: June 11, 2021
Gamma-H2AX Foci Decay Ratio as a Stronger Predictive Factor of Late Radiation Toxicity Than Dose-Volume Parameters in a Prospective Cohort of Prostate Cancer Patients.
Journal: International journal of radiation oncology, biology, physics
Published: May 20, 2021
Last Updated: 09/26/2026